Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 418.48M P/E - EPS this Y -6.70% Ern Qtrly Grth -
Income -16.39M Forward P/E 8.53 EPS next Y 24.30% 50D Avg Chg -29.00%
Sales 430.9M PEG - EPS past 5Y - 200D Avg Chg -47.00%
Dividend N/A Price/Book 0.93 EPS next 5Y - 52W High Chg -61.00%
Recommedations 2.00 Quick Ratio 0.93 Shares Outstanding 60.60M 52W Low Chg 1.00%
Insider Own 20.20% ROA 2.69% Shares Float 30.90M Beta -
Inst Own 67.37% ROE 2.83% Shares Shorted/Prior 0.94M/856.23K Price 6.82
Gross Margin 70.25% Profit Margin 4.50% Avg. Volume 288,366 Target Price 21.25
Oper. Margin 8.59% Earnings Date May 10 Volume 223,519 Change -7.21%
Bioventus Inc. News
06/22/22 Durham firm reworks $450M acquisition amid stock market volatility
06/21/22 Bioventus Amends CartiHeal Acquisition Structure
06/15/22 Implied Volatility Surging for Bioventus (BVS) Stock Options
05/10/22 Bioventus Inc. (BVS) Q1 2022 Earnings Call Transcript
05/10/22 Bioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance
05/04/22 With markets shaky, Durham firm scraps $415M plan to fund acquisition
05/03/22 Bioventus Cancels Proposed $415 Million Offering of Senior Notes; Reaffirms Full-Year 2022 Financial Guidance
05/02/22 Bioventus Agrees to Nationwide Contract with Cigna Commercial Plans for DUROLANEยฎ and GELSYN-3ยฎ for Knee Osteoarthritis
04/26/22 Durham company needs to raise $415M for deal. Here's how it's doing it.
04/26/22 Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA
04/26/22 Bioventus Announces $415 Million Offering of Senior Notes
04/25/22 Bioventus to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022
04/08/22 Bioventus TheraSkin Coverage Expands to Provide for 17 Million More Covered Lives
04/07/22 Some Investors May Be Worried About Bravura Solutions' (ASX:BVS) Returns On Capital
04/05/22 Bioventus Announces Inducement Equity to SVP Chief Financial Officer Mark Singleton
04/04/22 Bioventus Inc. (NASDAQ:BVS) Shares Could Be 47% Below Their Intrinsic Value Estimate
04/04/22 Durham public company adds to acquisition streak with $450M deal
04/04/22 Why Bioventus Stock Is Sinking Today
04/04/22 Bioventus Exercises Call Option to Acquire CartiHeal

Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies comprise an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

BVS Chatroom

User Image tickeron Posted - 13 hours ago

Is this good for your portfolio? $BVS's Aroon indicator drops into Downtrend on May 23, 2022. View odds for this and other indicators: https://srnk.us/go/3797169

User Image Last10K Posted - 1 day ago

$BVS just filed with the SEC a Event for Officers https://last10k.com/sec-filings/bvs/0001193125-22-185142.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=bvs

User Image cctranscripts Posted - 1 day ago

Departure of Directors or Certain https://www.conferencecalltranscripts.com/summary/?id=11031954 $BVS

User Image risenhoover Posted - 1 day ago

$BVS / Bioventus Inc. files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2022 Bioventus Inc. (Exa https://fintel.io/sf/us/bvs?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=filing

User Image Quantisnow Posted - 1 day ago

$BVS ๐Ÿ“œ Bioventus Inc. filed SEC Form 8-K: Leadership Update https://quantisnow.com/i/3091409?utm_source=stocktwits 45 seconds delayed.

User Image Newsfilter Posted - 1 day ago

$BVS Form 8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On June 27, 2022, John E. Nosenzo, Chi.. https://newsfilter.io/a/75a670cb8370e1bdbc87cf1a479b852f

User Image Quantisnow Posted - 1 week ago

$BVS Multiple insights just appeared: 1. ๐Ÿ“œ SEC Form 4 filed by Sutter Martin P https://quantisnow.com/i/3060078?utm_source=stocktwits 2. ๐Ÿ“œ SEC Form 4: Ladone Mary Kay converted options into 1,813 shares https://quantisnow.com/i/3060079?utm_source=stocktwits 3. ๐Ÿ“œ SEC Form 4: Mcmurry-Heath Michelle converted options into 385 shares https://quantisnow.com/i/3060080?utm_source=stocktwits 4. ๐Ÿ“œ SEC Form 4: Beyer Pat converted options into 965 shares https://quantisnow.com/i/3060082?utm_source=stocktwits 5. ๐Ÿ“œ SEC Form 4 filed by Stalnecker Susan M https://quantisnow.com/i/3060084?utm_source=stocktwits 6. ๐Ÿ“œ SEC Form 4: Vizirgianakis Stavros G. converted options into 965 shares, increasing direct ownership by 0.03% to 2,781,888 units https://quantisnow.com/i/3060085?utm_source=stocktwits 7. ๐Ÿ“œ SEC Form 4 filed by Hawkins William A https://quantisnow.com/i/3060087?utm_source=stocktwits 8. ๐Ÿ“œ SEC Form 4 filed by Nohra Guy P https://quantisnow.com/i/3060089?utm_source=stocktwits #healthcare

User Image Newsfilter Posted - 1 week ago

$BVS Form 4 (statement of changes in beneficial ownership of securities) filed with the SEC https://newsfilter.io/a/2a347155aeb68a5155155b225707f545

User Image Newsfilter Posted - 1 week ago

$BVS reported 7 new insider trades to the SEC in the last 2 minutes. 16,648 shares acquired by Hawkins William A (Director) https://newsfilter.io/articles/4-form-ea0924da4f4bd8ae497f6dc589673576 965 shares acquired by Beyer Pat (Director) https://newsfilter.io/articles/4-form-090018e58da671b7871ccdf07560485e 1,813 shares acquired by Ladone Mary Kay (Director) https://newsfilter.io/articles/4-form-11c4fbd83b060db123eb5c875993200a 965 shares acquired by Vizirgianakis Stavros G. (Director) https://newsfilter.io/articles/4-form-df463040c88e2b8dc41168471724fd9d 16,648 shares acquired by Sutter Martin P (Director) https://newsfilter.io/articles/4-form-76169d5f27ed29d6ee29f35d470a76fe 16,648 shares acquired by Stalnecker Susan M (Director) https://newsfilter.io/articles/4-form-0db818e5fa47e0e2c4b2bd9b149e7fab 385 shares acquired by Mcmurry-heath Michelle (Director) https://newsfilter.io/articles/4-form-1dd9491fc8409bb34f1bceacc01fb2aa

User Image Quantisnow Posted - 1 week ago

$BVS ๐Ÿ“œ SEC Form 4 filed by Neels Guido J https://quantisnow.com/i/3060076?utm_source=stocktwits 45 seconds delayed.

User Image Newsfilter Posted - 1 week ago

$BVS Form 4 (statement of changes in beneficial ownership of securities) filed with the SEC https://newsfilter.io/a/ab6593a3e9a1ae2923cc26aa9d73d940

User Image Newsfilter Posted - 1 week ago

$BVS Form 8-K: Entry into a Material Definitive Agreement.On June 17, 2022 the โ€œCompanyโ€) entered into an amendment to that certain Option and Equity Purchase Agreement, dated July 15, 2020, with Cart.. https://newsfilter.io/a/4e558fb6d274d3ab49eb9a8a2075132b

User Image Last10K Posted - 1 week ago

$BVS just filed with the SEC a New Agreement and a Financial Exhibit https://last10k.com/sec-filings/bvs/0001628280-22-017806.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=bvs

User Image cctranscripts Posted - 1 week ago

Entry into a Material Definitive https://www.conferencecalltranscripts.com/summary/?id=11003949 $BVS

User Image risenhoover Posted - 1 week ago

$BVS / Bioventus Inc. files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 17, 2022 Bioventus Inc. (Exa https://fintel.io/sf/us/bvs?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=filing

User Image Quantisnow Posted - 1 week ago

$BVS ๐Ÿ“œ Bioventus Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits https://quantisnow.com/i/3059601?utm_source=stocktwits 45 seconds delayed.

User Image Last10K Posted - 1 week ago

$BVS just filed with the SEC a Vote of Security Holders https://last10k.com/sec-filings/bvs/0001628280-22-017685.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=bvs

User Image Quantisnow Posted - 1 week ago

$BVS ๐Ÿ“œ Bioventus Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders https://quantisnow.com/i/3053729?utm_source=stocktwits 45 seconds delayed.

User Image Newsfilter Posted - 1 week ago

$BVS Form 8-K: Submission of Matters to a Vote of Security Holders.On June 17, 2022, Bioventus held its 2022 Annual Meeting of Stockholders. A total of 68,025,185 shares of Class A common stock and Cl.. https://newsfilter.io/a/1bdbbdeca9eaf12fd06bd82339dee7bb

User Image STCKPRO Posted - 1 week ago

$BVS NEW ARTICLE : Bioventus Amends CartiHeal Acquisition Structure https://www.stck.pro/news/BVS/29798025

User Image Stonkmoon Posted - 1 week ago

$BVS 2022-06-21 07:30 ET Bioventus Amends CartiHeal Acquisition Structure Bioventus, Inc. https://stonkmoon.com/news/BVS/5a4ab27ffc7b94aa53e79529bc1649f6

User Image fla Posted - 1 week ago

$BVS [15s. delayed]: Issued Press Release on June 21, 07:30:00: Bioventus Amends CartiHeal Acquisition Structure https://s.flashalert.me/5d9DL

User Image Quantisnow Posted - 1 week ago

$BVS ๐Ÿ“ฐ Bioventus Amends CartiHeal Acquisition Structure https://quantisnow.com/i/3049023?utm_source=stocktwits 45 seconds delayed.

User Image Stock_Titan Posted - 1 week ago

$BVS Bioventus Amends CartiHeal Acquisition Structure https://www.stocktitan.net/news/BVS/bioventus-amends-carti-heal-acquisition-ksh4syu5uhdu.html

User Image Newsfilter Posted - 1 week ago

$BVS Bioventus Amends CartiHeal Acquisition Structure https://newsfilter.io/a/b80fd4f1c967a42c4e7e0189ddcb836b

User Image oliveinvest Posted - 1 week ago

Simplify investing with strategies built on your criteria. See this fixed return outcome on $BVS Make a fixed 15.3% (27.0% annualized) BVS can fall 29% thru exp before you start to lose. Sell 2 $7.5 puts Exp 1/20/23 Capital Req. $1301.32 ๐Ÿ‘‰๐ŸผClick my profile link to see how its done.

User Image oliveinvest Posted - 2 weeks ago

150,000+ LIVE optimized option strategies -- here's one fixed return strategy for $BVS Make a fixed 12.7% (21.5% annualized) BVS can fall 27% thru exp before you start to lose. Sell 2 $7.5 puts Exp 1/20/23 Capital Req. $1331.32 ๐Ÿ‘‰๐ŸผClick my profile link to see how its done.

User Image EarningsInsider Posted - 3 weeks ago

$BVS updates FY 2022 guidance to EPS and revenue guidance to $545.00 million-$565.00 million. https://www.marketbeat.com/g/101578

User Image oliveinvest Posted - 4 weeks ago

Good โœจoptions, such as this fixed return strategy for $BVS Make a fixed 12.1% (34.2% annualized) BVS can fall 26% thru exp before you start to lose. Buy 1 $5 put Sell 2 $7.5 puts Exp 10/21/22 Capital Req. $891.98 ๐Ÿ‘‰๐ŸผClick my profile link to see how its done.

User Image EarningsInsider Posted - 1 month ago

$BVS updates FY 2022 guidance to EPS and revenue guidance to $545.00 million-$565.00 million. https://www.marketbeat.com/g/100432

Analyst Ratings
Goldman Sachs Neutral Mar 21, 22
Craig-Hallum Buy Mar 15, 22
Morgan Stanley Overweight Mar 11, 22
Goldman Sachs Neutral Jul 1, 21
Morgan Stanley Overweight Apr 19, 21
Canaccord Genuity Buy Mar 8, 21
Morgan Stanley Overweight Mar 8, 21
JP Morgan Overweight Mar 8, 21
Goldman Sachs Buy Mar 8, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Vizirgianakis Stavros G. Director Director Jun 16 Option 0.00 965 2,781,888 06/22/22
Beyer Pat Director Director Jun 16 Option 0.00 965 965 06/22/22
McMurry-Heath Michelle Director Director Jun 16 Option 0.00 385 385 06/22/22
Ladone Mary Kay Director Director Jun 16 Option 0.00 1,813 1,813 06/22/22
D'Adamio Anthony SVP & General Counse.. SVP & General Counsel Apr 01 Sell 11.19 16,016 179,219 40,132 04/05/22
Nosenzo John Chief Commercial Off.. Chief Commercial Officer Apr 01 Sell 11.12 65,963 733,509 83,932 04/05/22
Pavesio Alessandra SVP & Chief Science.. SVP & Chief Science Officer Apr 01 Sell 11.17 32,997 368,576 148,309 04/05/22
Pavesio Alessandra SVP & Chief Science.. SVP & Chief Science Officer Feb 14 Sell 11.99 433 5,192 119,830 02/16/22
D'Adamio Anthony SVP & General Counse.. SVP & General Counsel Feb 11 Sell 11.99 1,294 15,515 18,672 02/15/22
Anglum Gregory O. SVP & CFO SVP & CFO Feb 11 Sell 11.99 1,294 15,515 55,013 02/15/22
Nosenzo John Chief Commercial Off.. Chief Commercial Officer Feb 11 Sell 11.99 534 6,403 43,370 02/15/22